MIB Seminar (in English)
FY 2018
- Targeting Cell Signaling Pathways for Cancer Therapies. Prof. Wenyi Wei （2019.03.05）
- GLP and drug safety studies- Hints for academic researchers. Abbas Fotovati, DVM, PhD （2019.02.18）
- Ferroptosis in Cancer Research. Prof. Shinya Toyokuni （2019.01.29）
- First-in-class drug development strategy for Parkinson’s disease via interruption of death signaling. Dr. Eunhee Kim (2018.11.21)
- Epigenetics in the male germline from stem cells to sperm. Dr. Satoshi Namekawa (2018.11.15)
- Democratizing Health Innovation, Dr. Martin Burke (2018.11.13)
- The Role of OGG1 in doxorubicin-induced cardiotoxicity. Dr. Chukwuemeka George Anene-Nzelu (2018.11.01)
- Epigenetic pathways as targets in human disease. Prof. Shelley L. Berger (2018.09.05)
- Regulations of mitotic processes by nucleosomes — molecular principles and implications in cancer biology and immunology. Hironori Funabiki, Ph.D. (2018.06.20)